- You can view the full AstraZeneca Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The drug would be the first such treatment in Europe.
One of the hottest biotech stocks of the last month is selling off.
Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.
A glimpse of what to expect during Tuesday's pre-market.